Factors Associated With Acute Telogen Effluvium And COVID-19 Infection

February 2025 in “ Indus journal of bioscience research. ”

Faryal Nawab, Farina Zameer, Salman Ahmed, Tooba Hanif, Nimrah Sarwar Awan, Shahbaz Aman

Acute Telogen Effluvium COVID-19 PCR diabetes temporal region dietary supplements hair loss TE PCR test temporal area supplements

Studysummary In this descriptive cross-sectional study conducted at a Karachi hospital, researchers found a high prevalence of Telogen Effluvium in female COVID-19 survivors, particularly those with diabetes, and noted that dietary supplementation may be linked to reduced hair loss severity post-infection.

Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer

This study investigates the prevalence and factors associated with Acute Telogen Effluvium (TE) in COVID-19 patients. Conducted at Sohail Trust Hospital in Karachi, the study involved 100 COVID-19 PCR-positive patients from January to July 2022. Results showed that 64% of female participants experienced TE post-COVID-19, with diabetes being the most common co-morbidity. The temporal region was the most affected area, and lack of dietary supplements was linked to severe hair loss. Additionally, 34.6% of those with hair loss reported similar issues in family members post-COVID-19. Only 7% sought professional treatment, highlighting the need for greater awareness and treatment accessibility for TE in COVID-19 survivors.

View this study on ijbr.com.pk →

Discuss this study in the Community →

Research cited in this study

9 / 9 results

research SARS-CoV-2 Infection as a Trigger for Telogen Effluvium: A Literature Review with Case-Based Clinical Evaluation Guidance

2 citations , July 2023 in “Life”

This study reports that telogen effluvium, a reversible hair loss condition following COVID-19, is influenced by factors like stress and inflammation, but appropriate dermatological treatment can aid recovery, as highlighted by a clinical case example.

research Intermittent Chronic Telogen Effluvium With an Unusual Dermoscopic Finding Following COVID-19

2 citations , August 2022 in “Clinical Case Reports”

This case report describes a 17-year-old girl with telogen effluvium and severe hair loss following a suspected COVID-19 infection and a history of similar episodes since childhood.

research Prevalence of Telogen Effluvium Hair Loss in COVID-19 Patients and Its Relationship with Disease Severity

8 citations , May 2022 in “Journal of medicine and life”

This study found that telogen effluvium, a type of hair loss, was prevalent among 24% of COVID-19 patients, likely triggered by stress and medication related to the illness.

research Complementary Strategies to Promote Hair Regrowth in Post-COVID-19 Telogen Effluvium

3 citations , April 2022 in “Clinical, Cosmetic and Investigational Dermatology”

This review discusses evidence-based complementary strategies for enhancing hair regrowth after post-COVID-19 telogen effluvium and reports no new clinical results.

research Association of Androgenetic Alopecia and Severity of Coronavirus Disease 2019

4 citations , December 2021 in “Journal of Cosmetic Dermatology”

This observational study found a significant association between the severity of androgenetic alopecia and worse COVID-19 outcomes in men compared to women, suggesting potential value in anti-androgen treatments.

research Evaluation of the Effects of COVID-19 Pandemic on Hair Diseases Through a Web-Based Questionnaire

39 citations , June 2020 in “Dermatologic Therapy”

In this study, individuals reported a decrease in dermatologist visits for hair and scalp conditions like telogen effluvium and alopecia areata during COVID-19 quarantine, despite increased occurrences.

research Female Pattern Alopecia and Telogen Effluvium: Figuring Out Diffuse Alopecia

25 citations , June 2015 in “Seminars in Cutaneous Medicine and Surgery”

This article discusses methods to distinguish and manage female pattern alopecia and telogen effluvium in women with diffuse hair loss but reports no new clinical results.

research Telogen Effluvium: A Review

70 citations , January 2015 in “Journal of Clinical and Diagnostic Research”

This review discusses the various triggers and diagnostic challenges in determining the cause of telogen effluvium-related hair loss, without providing new clinical results.

research Does D Matter? The Role of Vitamin D in Hair Disorders and Hair Follicle Cycling

98 citations , February 2010 in “Dermatology Online Journal”

This article outlines the potential for upregulating the vitamin D receptor in treating hair disorders, emphasizing the need for further studies to evaluate vitamin D's role in the hair cycle.